- Zacks•6 hours ago
Shares of Achillion Pharmaceuticals, Inc. (ACHN) lost almost 9% on Feb 24, 2017, in spite of the company reporting narrower-than-expected fourth-quarter loss a day before.
- Zacks•3 days ago
Emergent BioSolutions, Inc. (EBS) reported earnings of 74 cents per share in the fourth quarter of 2016, which surpassed the Zacks Consensus Estimate of 60 cents. However, the reported figure decreased from 77 cents earned in the year-ago period.
- Zacks•4 days ago
Bayer AG's (BAYRY) fourth-quarter 2016 core earnings increased 10.2% year over year to ???1.19 per share (approximately $1.28). Reported earnings missed the Zacks Consensus Estimate of $1.37.
SNSS : Summary for Sunesis Pharmaceuticals, Inc. - Yahoo Finance
Sunesis Pharmaceuticals, Inc. (SNSS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||4.27 x 100|
|Ask||4.30 x 100|
|Day's Range||4.23 - 4.45|
|52 Week Range||2.64 - 6.30|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.47|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|